Pattern of medication dispensations for attention-deficit/hyperactivity disorder in Manitoba children, adolescents and young: a population-wide retrospective study

CONCLUSIONS: Stimulant and non-stimulant dispensations for ADHD increased from 2015 to 2023, consistent with international findings. The increase was observed to be the greatest in the population 19 to 24 years of age and females. While there was a significant increase in most ADHD medications, there was a pronounced increase in lisdexamphetamine and guanfacine, specifically.

via https://pubmed.ncbi.nlm.nih.gov/42767722/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20260922010803&v=2.20.1